×

Morgan Stanley M&A head on Valeant

7:45 AM ET Mon, 16 June 2014

Robert Kindler, vice chairman and head of mergers and acquisitions at Morgan Stanley, gives CNBC an update on Valeant's efforts to buy Botox-maker Allergan